期刊文献+

慢性心力衰竭合并肾功能不全相关危险因素分析 被引量:34

Analysis of relevant risk factors for chronic heart failure complicated with renal insufficiency
下载PDF
导出
摘要 目的分析慢性心力衰竭(CHF)患者合并肾功能不全的临床特点,探讨CHF患者伴发肾功能不全的危险因素。方法收集就诊于本院心内科的CHF患者385例,其中男性211例,女性174例,平均年龄69.62±8.59岁。采用回顾性对照研究的方法,按照肾小球滤过率估计值(eGFR)将CHF患者分为肾功能不全组[eGFR<60 mL/(min·1.73 m^2)]和非肾功能不全组[eGFR≥60 mL/(min·1.73 m2)]。分析比较两组患者的一般资料、心脏基础疾病、伴随疾病、对比剂应用史、心脏超声参数、肾功能指标、血脂、N末端B型利钠肽前体(NT-proBNP)、D-二聚体、血红蛋白、尿微量白蛋白等实验室检查结果。多因素Logistic回归分析CHF患者合并肾功能不全的危险因素。结果385例CHF患者中合并肾功能不全的发生率约为42.1%。单因素分析结果显示,年龄、NYHA心功能分级、高血压病、贫血、糖尿病、心房颤动在肾功能不全组和非肾功能不全组之间的差异有统计学意义(P<0.05);肾功能不全组血清肌酐、尿素氮、尿酸、胱抑素C和NT-proBNP水平较非肾功能不全组升高;左心室射血分数和血红蛋白水平较非肾功能不全组降低,差异有统计学意义(P<0.05)。多因素Logistic回归分析显示,年龄(OR 1.543,95%CI1.067~2.231)、NYHA心功能分级(OR 1.840,95%CI 1.054~3.212)、高血压病史(OR 1.967,95%CI 1.175~3.292)以及胱抑素C(OR 1.989,95%CI 1.027~3.851)与肾功能不全的发生独立相关。结论 CHF患者合并肾功能不全的发生率较高,高龄、NYHA心功能Ⅳ级、高血压病史以及血清高胱抑素C水平是CHF患者合并肾功能不全的独立危险因素。 Aim To analyze the clinical features of patients with chronic heart failure (CHF) complicated with renal insufficiency,and to explore the risk factors of CHF with renal insufficiency.Methods 385 cases of CHF patients who were treated in department of cardiology of our hospital were collected,including 211 males and 174 females,with an average age of 69.62±8.59 years.Applying method of retrospective control study,according to estimated glomerular filtration rate (eGFR),the CHF patients were divided into renal insufficiency group [eGFR〈60 mL/(min · 1.73 m2)]and non renal insufficiency group [eGFR ≥ 60 mL/(min · 1.73 m2)].The general information,heart basic diseases,concomitant disease,contrast agent application history,echocardiographic parameters,renal function,blood lipids,N-terminal pro-B-type natriuretic peptide (NT-proBNP),D-dimer,hemoglobin,urine microalbumin and other laboratory examination indexes were analyzed and compared between the two groups.Multivariate Logistic regression was used to analyze the risk factors of CHF patients with renal insufficiency.Results The incidence of renal insufficiency was about 42.1% in 385 patients with CHF.Univariate analysis showed that the differences of age,NYHA heart function classification,hypertension,anemia,diabetes,atrial fibrillation were statistically significant between renal insufficiency group and non renal insufficiency group (P〈0.05).The levels of serum creatinine,urea nitrogen,uric acid,cystatin C and NT-proBNP in renal insufficiency group were higher than those in non renal insufficiency group,and left ventricular ejection fraction and hemoglobin level were lower than those in non renal insufficiency group (P〈0.05).Multivariate Logistic regression analysis showed that age (OR 1.543,95%CI 1.067-2.231),NYHA heart function classification (OR 1.840,95%CI 1.054-3.212),hypertension (OR 1.967,95%CI 1.175-3.292) and cystatin C (OR 1.989,95%CI 1.027-3.851)were independently associated with renal insufficiency.Conclusion The incidence of renal insufficiency was higher in patients with CHF.The eider age,NYHA heart function Ⅳ classification,hypertension and serum cystatin C were independent risk factors of CHF patients with renal insufficiency.
出处 《中国动脉硬化杂志》 CAS 北大核心 2017年第6期604-609,共6页 Chinese Journal of Arteriosclerosis
关键词 慢性心力衰竭 肾功能不全 危险因素 Chronic heart failure Renal insufficiency Risk factor
  • 相关文献

参考文献2

二级参考文献53

  • 1尤丹瑜,万建新,吴可贵.高血压肾损害[J].中华高血压杂志,2007,15(4):275-277. 被引量:69
  • 2Wang B, Sun J, Kitamoto S, et al. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors [J]. J Biol Chem, 2006, 281(9) : 6 020-029.
  • 3Eriksson P, Deguchi H, Samnegard A, et al. Human evidence that the cystatin C gene is implicated in focal progression of coronary artery disease [ J ]. Arterioscler Thromb Vasc Biol, 2004, 24 (3) : 551-557.
  • 4Loew M, Hoffmann MM, Koenig W, et al. Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events [ J ]. Arterioscler Thromb Vasc Biol, 2005, 25 (7) : 1 470-474.
  • 5Fricker M, Wiesli P, Brandle M, et al. Impact of thyroid dysfunction on serum cystatin C [ J ]. Kidney Int, 2003, 63 (5) : 1 944-947.
  • 6Liu J, Sukhova GK, Sun JS, et al. Ysosomal cysteine proteases in atherosclerosis [ J ]. Arterioscler Thromb Vasc Biol, 2004, 24(8) : 1 359-366.
  • 7Bengtsson E, Nilsson J, Jovinge S. Cystatin C and cathepsins in cardiovascular disease [ J ]. Front Biosci, 2008, 13 : 5 780-786.
  • 8Leena L, Miriam L, Katariin C, et al. Cathepsins F and S block HDL3-induced cholesterol efflux from macrophage foam cells [ J]. Biochem Biophys Res Commun, 2003, 312(4) : 1 019-024.
  • 9Sukhova GK, Wang B, Libby P, et al. Cystatin C deficiency increases elastic lamina degradation and aortic dilatation in apolipoprotein E-null mice [ J ]. Circ Res, 2005, 96(3): 368-375.
  • 10Bengtsson E, To F, Hakansson K, et al. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice [ J ]. Arterioscler Thromb Vasc Biol, 2005, 25(10): 2 151-156.

共引文献23

同被引文献342

引证文献34

二级引证文献226

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部